Lucid Diagnostics Inc. Common Stock (LUCD) is a publicly traded Healthcare sector company. As of November 12, 2026, LUCD trades at $0.42 with a market cap of $76.38M and a P/E ratio of -1.39. LUCD moved +10.38% today. Year to date, LUCD is -65.58%; over the trailing twelve months it is -62.60%. Its 52-week range spans $0.30 to $1.80. Analyst consensus is strong buy with an average price target of $4.00. Rallies surfaces LUCD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LUCD insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.42 |
| Market Cap | $76.38M |
| P/E Ratio | -1.39 |
| EPS | $-0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.80 |
| 52-Week Low | $0.30 |
| Volume | 5.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.45M |
| Net Income | $-52.26M |
| Gross Margin | -21.69% |
5 analysts cover LUCD: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.00.